Absolute Return Capital’s Halozyme HALO Stock Holding History

Absolute Return Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-21,192	Closed	-$209K	–	750
2014 Q2	$209K	Buy	21,192 +19,142	+934%	+$162K	﹤0.01%	1011
2014 Q1	$26K	Buy	+2,050	New	+$30.4K	﹤0.01%	1199

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Absolute Return Capital's HALO Position: Q3 2014 in Review

Absolute Return Capital sold out of Halozyme (HALO) in Q3 2014, closing a stake of 21,192 shares — an estimated $209K sold.

Absolute Return Capital first reported a position in HALO in Q1 2014 and held it in 2 quarters. The position peaked at $209K in Q2 2014. 121 funds tracked by Wall St. Rank hold HALO as of Q3 2014.

Absolute Return Capital reported no remaining Halozyme position as of Q3 2014 after selling out during the quarter.
Absolute Return Capital sold 21,192 Halozyme shares in Q3 2014, an estimated $209K.
Absolute Return Capital first reported a position in Halozyme in Q1 2014 and held it in 2 quarters.
Absolute Return Capital's Halozyme position peaked at $209K in Q2 2014.
121 funds tracked by Wall St. Rank held Halozyme as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.